Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
WALTHAM, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company will participate in the following investor conferences:
Each conference event will be available via a live webcast from the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcasts will be available for 90 days following the event.
Press Room Open for Registered Media, Analysts, Speakers, Exhibitors - Sponsored by Parallel Communications
Scaling & Managing Real-time Communication Workloads in Kubernetes
Solutions Showcase Theatre Presentations on Expo Floor